Search alternatives:
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
341
Characteristics of HACE respondents by year.
Published 2025“…</p><p>Results</p><p>Overall patient satisfaction with general practice declined significantly over the 10 years, with mean positive scores dropping from 90.1% in 2011/12 to 70.5% in 2021/22. …”
-
342
-
343
ECoG timescales decrease during spatial attention.
Published 2025“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
-
344
-
345
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
346
-
347
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
348
-
349
-
350
-
351
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
352
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
353
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
354
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
355
-
356
-
357
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
358
-
359
-
360